Literature DB >> 6082926

[Quantitative considerations on the problems of preventive surgery].

I Staib, H Köbler.   

Abstract

Mesh:

Year:  1967        PMID: 6082926     DOI: 10.1007/bf01439530

Source DB:  PubMed          Journal:  Langenbecks Arch Chir        ISSN: 0023-8236


× No keyword cloud information.
  43 in total

1.  [NEW VIEWPOINTS ON THE DIAGNOSIS AND THERAPY OF THE MALIGNANT GOITER].

Authors:  H FRANKE; W BOERNER
Journal:  Langenbecks Arch Klin Chir Ver Dtsch Z Chir       Date:  1965-03-05

2.  [Clinical aspects and therapy of struma maligna].

Authors:  R PARHOFER; S KARNBAUM
Journal:  Munch Med Wochenschr       Date:  1963-07-19

3.  Cancer of the thyroid.

Authors:  W J FRY; R M ONEAL; R W SCHMIDT; M S DEWEESE
Journal:  Surg Clin North Am       Date:  1961-10       Impact factor: 2.741

4.  Further studies in the surgical management of carcinoma of the lung; a further study of the cases treated at the Massachusetts General Hospital from 1950 to 1957.

Authors:  E D CHURCHILL; R H SWEET; J G SCANNELL; E W WILKINS
Journal:  J Thorac Surg       Date:  1958-09

5.  Carcinoma of the stomach; necessity for reevaluation of therapeutic philosophy.

Authors:  A OCHSNER; J BLALOCK
Journal:  J Am Med Assoc       Date:  1953-04-18

6.  Risk of serious infection following splenectomy.

Authors:  A G Lowdon; R H Stewart; W Walker
Journal:  Br Med J       Date:  1966-02-19

7.  Precancerous lesions of the colon and rectum. Classification and controversial issues.

Authors:  B C MORSON
Journal:  JAMA       Date:  1962-02-03       Impact factor: 56.272

8.  The association of chronic ulcerative colitis and carcinoma of the rectum and colon.

Authors:  P B COUNSELL; C E DUKES
Journal:  Br J Surg       Date:  1952-05       Impact factor: 6.939

9.  [Respect for life. 4. The respect for life from the viewpoint of a surgeon].

Authors:  R Nissen
Journal:  Hippokrates       Date:  1965-07-31

10.  [Surgical treatment of ulcerative colitis].

Authors:  F Deucher
Journal:  Dtsch Med Wochenschr       Date:  1966-05-27       Impact factor: 0.628

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.